Academic literature on the topic 'Breast – Cancer – Psychological aspects'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Breast – Cancer – Psychological aspects.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Breast – Cancer – Psychological aspects"

1

Pittermann, Anna, and Christine Radtke. "Psychological Aspects of Breast Reconstruction after Breast Cancer." Breast Care 14, no. 5 (2019): 298–301. http://dx.doi.org/10.1159/000503024.

Full text
Abstract:
Even though breast cancer mortality is declining, the diagnosis still poses a huge threat for the affected woman and her close family. Breast cancer surgery, which often includes reconstructive procedures, can help restoring a satisfactory body image. The decision on the type of surgery should always be made together with the patient and should focus on her psychosocial needs. This review describes the psychological aspects of breast cancer for the patient and her social environment and offers ideas for a patient-oriented treatment plan.
APA, Harvard, Vancouver, ISO, and other styles
2

Blumberg, Barbara D. "Psychological aspects of early breast cancer." Patient Education and Counseling 10, no. 3 (December 1987): 310–12. http://dx.doi.org/10.1016/0738-3991(87)90135-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Blumberg, Barbara D. "Psychological aspects of early breast cancer." Patient Education and Counseling 11, no. 2 (April 1988): 161–63. http://dx.doi.org/10.1016/0738-3991(88)90052-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

ali Kunhikkandy, Ashkar. "INSIGHT TO PSYCHOLOGICAL ASPECTS OF BREAST CANCER." Breast 59 (October 2021): S60—S61. http://dx.doi.org/10.1016/s0960-9776(21)00575-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Timms, Michael W. H. "Aspects of psychological intervention with breast cancer patients." Irish Journal of Psychological Medicine 7, no. 2 (September 1990): 168–76. http://dx.doi.org/10.1017/s0790966700016815.

Full text
Abstract:
AbstractThe paper makes a chronological review of the literature in the area of psychological intervention with cancer patients, focussing particularly on breast cancer as this is the disease which has attracted most attention from mental health profesionals. Initially, surveys which identify psychological distress in cancer patients are reviewed, as it is felt that these may have contributed the impetus for intervention. In the second half of the paper, interventions are classified and reviewed.
APA, Harvard, Vancouver, ISO, and other styles
6

Magarey, Christopher J. "Aspects of the psychological management of breast cancer." Medical Journal of Australia 148, no. 5 (March 1988): 239–42. http://dx.doi.org/10.5694/j.1326-5377.1988.tb99433.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kunhikkandy, Ashkar Ali. "Insight to Psychological Aspects of Cancer." BJPsych Open 8, S1 (June 2022): S56—S57. http://dx.doi.org/10.1192/bjo.2022.206.

Full text
Abstract:
AimsThe baseline of this study 1)What is the type of psychiatric disturbances in oncology settings?2)Is there any importance in cancer education?3)How to manage psychiatric disturbances?MethodsAs of lockdown concerning COVID-19, this study is conducted online among 20 cancer patients. This is a cross-sectional study where Each patient has explained the purpose of the study, procedures, and consent was taken from patients then a questionnaire was given, and this was assessed. Among the profile of the study population, 50% were males and 50% were females of the total study population, 60% were married and 40% were unmarried, Participants were aged between 22 and 63 years. The study population also consists of 20% are breast cancer, 25% lung cancer,10% lung cancer, and the rest are other types of cancers. Patient details are collected from the Facebook groups for cancer patients. Assessment has 2 parts, one is based on CES-D Test where each individual was each patient answered 20 question and next part is based on 5 questions regarding Financial Depression, Behavioral changes, Feelings, Education about cancer and Psychiatric support.ResultsIt is found that 60% population are normal, 25% had mild Depression, 10% have moderate Depression followed by 5% with severe depression.Among associations between marital status and various disorders, it was found that psychological disturbances are 2 times fold more in married people while compared to unmarried. There is also an association between treatment modalities are observed, in that anxiety is prevalent with people who had chemotherapy. Based on education and financial status, those who are with less education about cancer and less financially stable have also prominent disturbances.ConclusionThe study was based on other research study related to the spectrum of psychological disturbance based on treatment stage, financial status, awareness of cancer among patients, and role of marital status among individuals Offering mental health services to patients with cancer is becoming an integral part of oncologic treatments because psychological problems harm cancer management. The most common psychiatric disorders in cancer patients are depression, anxiety disorders, and adjustment disorders. Psychiatrists should be involved in the multidisciplinary treatment team that works with cancer patients. Further research is needed to determine the effectiveness of different psychological and psychopharmacological interventions in psycho-oncology and palliative medicine
APA, Harvard, Vancouver, ISO, and other styles
8

Ingram, Michael A. "Psycho-Social Aspects of Breast Cancer." Journal of Applied Rehabilitation Counseling 20, no. 2 (June 1, 1989): 23–27. http://dx.doi.org/10.1891/0047-2220.20.2.23.

Full text
Abstract:
Because of the high Incidence, and the possible resulting vocational disability it is very likely that rehabilitation counselors, particularly those employed in medical settings and the state, federal system, will work with women who have breast cancer and are eligible for services. Cancer of the breast may have significant impact on the emotional and psychological constructs of the individual, as it affects not only the patient, but her family as well and may interfere with, and disrupt the organization of the family, social, financial, education, vocational goals, and indeed the very definition of the family unit. Suggestions are made for some counseling techniques which may be used in dealing with these problems.
APA, Harvard, Vancouver, ISO, and other styles
9

Heimes, Anne-Sophie, Kathrin Stewen, and Annette Hasenburg. "Psychosocial Aspects of Immediate versus Delayed Breast Reconstruction." Breast Care 12, no. 6 (2017): 374–77. http://dx.doi.org/10.1159/000485234.

Full text
Abstract:
Background: Only little is known about the psychosocial aspects of breast cancer patients after mastectomy with immediate versus delayed breast reconstruction. Methods: We systematically screened PubMed using the following key words: mastectomy, immediate vs. delayed reconstruction, psychosocial aspects and quality of life. To highlight different psychological outcomes, studies were categorized into those describing: anxiety, depression, body image and satisfaction with the surgical outcome. We also compared patients after mastectomy alone with those undergoing immediate or delayed reconstruction. Results: Methodologies and psychological outcomes varied among the identified studies, making it difficult to compare results. There are contradictory outcomes concerning the psychosocial aspects of breast cancer patients after mastectomy alone compared with those who underwent an immediate or delayed reconstruction following mastectomy. Some studies show that immediate reconstruction after mastectomy had a positive impact on patients' psychological well-being. In contrast, other studies indicated that in the long-term view the compared patient groups were very similar concerning psychosocial aspects. Conclusion: Analyzing different aspects of psychosocial well-being after breast cancer surgery, there might be an advantage in choosing immediate reconstruction, if oncological safety allows it.
APA, Harvard, Vancouver, ISO, and other styles
10

Carlsson, Marianne, and Elisabeth Hamrin. "Psychological and psychosocial aspects of breast cancer and breast cancer treatment; A literature review." Cancer Nursing 17, no. 5 (October 1994): 418???428. http://dx.doi.org/10.1097/00002820-199410000-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Breast – Cancer – Psychological aspects"

1

Cerna, Zuzana. "Psychological preparedness for breast cancer surgery." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp02/NQ56522.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mak, Wai-ming Vivian. "Psychological predictors of marital adjustment in breast cancer patients." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1998. http://hub.hku.hk/bib/B29726426.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Poon, Yuet-fai Helena. "The psychological reactions of breast cancer patients with mastectomy." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1996. http://hub.hku.hk/bib/B29697475.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jarvis, Renee Lauren. "Factors participants value in breast cancer support groups." CSUSB ScholarWorks, 2007. https://scholarworks.lib.csusb.edu/etd-project/3112.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Amor, Lynne. "What is the intimate experience of couples following the woman's cancer-related breast surgery?" Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 1997. https://ro.ecu.edu.au/theses/919.

Full text
Abstract:
The purpose of this phenomenological study is to describe and interpret the experience of couples following the woman's surgery for breast cancer, in order to gain an in depth understanding of how this mutilating surgery affects their everyday lives. Breast cancer is the most prevalent form of cancer in Australian women, and in most industrialised nations. Women in Australia have a one in fourteen lifetime risk of developing the disease. Little is known concerning what meanings this surgery brings to the intimacy experienced between partners. It is important to seek knowledge of the phenomenon of intimacy, how the couples understand it, and how breast surgery has affected it, if at all. Literature to date has focused on the psychological and physiological effects of mastectomy on women, with little attention given to the plight of partners. A phenomenological approach was chosen for the study, and a purposive sample of seven couples was selected for the interviews. Primary data was obtained from audio taped interviews and from participant observation. Data analysis followed the protocol outlined by Colaizzi (1978), and seeks to describe, interpret and extrapolate common themes and meanings from the data.
APA, Harvard, Vancouver, ISO, and other styles
6

Neuling, Sandra J. "Psychosocial needs and responses in breast cancer recovery /." Title page, contents and abstract only, 1989. http://web4.library.adelaide.edu.au/theses/09PH/09phn487.pdf.

Full text
Abstract:
Thesis (Ph. D.)--Dept. of Psychology, University of Adelaide, 1991.
Typescript (Photocopy). Includes two papers co-authored by the author as appendix D. Includes bibliographical references (leaves 397-425).
APA, Harvard, Vancouver, ISO, and other styles
7

Hackman, Marcia. "Coping strategies of women with breast cancer." Thesis, The University of Arizona, 1988. http://hdl.handle.net/10150/276869.

Full text
Abstract:
An ethnographic study was utilized to identify coping strategies of women with breast cancer. Five women were interviewed; four were interviewed on three separate occasions, and one was interviewed twice. The data were analyzed for specific coping strategies taken by the women to deal with the stresses of breast cancer. These strategies were compared and organized into categories of coping strategies: Actions Taken, Emotional Support, Positive Outcomes, Getting Control, and Keeping a Positive Attitude. These five categories were integrated as new coping incidents appeared in the data. The original five categories were merged into three categories: Getting Control, Compensating, and Emotional Support. From these three categories the theory was written: Women with breast cancer will obtain support, get control over what they can control, and compensate for what they cannot control.
APA, Harvard, Vancouver, ISO, and other styles
8

Bassett-Smith, Joan L. "Women with breast cancer and their living in and through discourses : a feminist postmodern study." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/NQ58558.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lesniak, Karen. "Psychological and Sociodemographic Predictors of Psychological Distress in BRCA1 and BRCA2 Genetic Testing Participants within a Community Based Genetic Screening Program." Thesis, University of North Texas, 2000. https://digital.library.unt.edu/ark:/67531/metadc2565/.

Full text
Abstract:
Mutations in BRCA1 and BRCA2, the first two breast cancer susceptibility genes identified, carry as much as an 85% lifetime risk of developing breast, ovarian or other cancers. Genetic testing for mutations in these two genes has recently become commercially available. There have been varying amounts of psychological distress noted among women with a family history of breast cancer. Distress has been observed to impact psychological functioning, activities of daily living, and the practice of breast cancer surveillance behaviors. Within the genetic screening process, psychological distress has been shown to impact the decision to undergo genetic screening, the comprehension and retention of risk assessment information, as well as affecting the subject following the receipt of the genetic test results. Little work has been done to examine predictors of distress within at risk subjects. This study examines psychological distress among 52 community women presenting for BRCA1 and BRCA2 genetic mutation testing. Predictors of distress included family cancer history, education, age, Ashkenazi ethnicity, and Internality and Powerful Others Health Locus of Control. Vulnerable sub-groups of patients include younger women, women with higher levels of education and women of Ashkenazi ethnicity.
APA, Harvard, Vancouver, ISO, and other styles
10

Price, Melanie Anne. "Psychosocial variables in the development of breast cancer." Phd thesis, Department of Psychological Medicine, 2002. http://hdl.handle.net/2123/7776.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Breast – Cancer – Psychological aspects"

1

Michael, Baum, ed. Psychological aspects of early breast cancer. New York: Springer-Verlag, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ray, Colette, and Michael Baum. Psychological Aspects of Early Breast Cancer. New York, NY: Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4613-8563-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Andrew, Clark, ed. Breast cancer. London: Tavistock/Routledge, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sandra, Haber, and Acuff Catherine, eds. Breast cancer: A psychological treatment manual. New York: Springer Pub. Co., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Breast cancer: A soul journey. Asheville, North Carolina: Chiron Publications, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Spinning straw into gold: Your emotional recovery from breast cancer. New York: Simon & Schuster, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kaye, Ronnie. Spinning straw into gold: Your emotional recovery from breast cancer. New York: Simon & Schuster, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

The psychological impact of breast cancer: A psychologist's insights as a patient. Oxford: Radcliffe Publishing, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Manne, Sharon L. Coping with breast cancer: Workbook for couples. New York: Oxford Univ Press, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Eiler, Larry T. When the woman you love has breast cancer. Ann Arbor, Mich: Queen Bee Pub. Co., 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Breast – Cancer – Psychological aspects"

1

Veronesi, Umberto. "Psychological Aspects." In Breast Cancer, 63–65. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-76054-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tait, Ann. "Psychological aspects of breast cancer." In Breast Cancer Nursing, 15–45. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4899-3388-1_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Shakin, E., J. Rowland, and J. Holland. "Psychological Aspects of Breast Cancer: One Nation’s Approach to an International Problem." In Breast Cancer, 89–99. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83675-6_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lynch, Henry T., Patrice Watson, Theresa A. Conway, and Jane F. Lynch. "Monitoring High Risk Women: Psychological Aspects." In Approaches to Breast Cancer Prevention, 191–205. Dordrecht: Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3742-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ashcroft, J. J., P. D. Slade, and S. Leinster. "Psychological Aspects of Breast Cancer Treatment." In Current Issues in Clinical Psychology, 173–81. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4615-6778-3_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ray, Colette, and Michael Baum. "Breast Cancer and Its Treatment." In Psychological Aspects of Early Breast Cancer, 1–11. New York, NY: Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4613-8563-9_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ray, Colette, and Michael Baum. "The Stress of Breast Cancer." In Psychological Aspects of Early Breast Cancer, 12–27. New York, NY: Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4613-8563-9_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Howard, A. Fuchsia, Lynda G. Balneaves, and Arminée Kazanjian. "Mastectomy to Prevent Breast Cancer: Psychosocial Aspects of Women’s Decision-Making." In Psychological Aspects of Cancer, 65–73. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-4866-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ray, Colette, and Michael Baum. "Cancer: A Psychosomatic Disease?" In Psychological Aspects of Early Breast Cancer, 85–100. New York, NY: Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4613-8563-9_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ray, Colette, and Michael Baum. "Cancer Attitudes and Related Behavior." In Psychological Aspects of Early Breast Cancer, 69–84. New York, NY: Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4613-8563-9_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Breast – Cancer – Psychological aspects"

1

Sarh, K., K. Ravi-Chandar, M. Miller, and C. Patrick. "Towards a Biomechanical Model of the Breast: A Simulation-Based Study." In ASME 2001 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2001. http://dx.doi.org/10.1115/imece2001/bed-23068.

Full text
Abstract:
Abstract The clinical and financial impact of breast cancer on the U. S. health care system is great. In addition to the tangible metrics of costs and number of diagnoses, the psychological distress that accompanies a lump found in the breast is compounded by the apparent problems noted with contemporary reconstructive procedures. Currently, breast reconstruction is conducted largely by trial and error and varies with physician experience. For instance, a surgeon today will request three to four different sized implants for the operating room and will try each one, siting the patient up each time, until the desired volume and shape of the breast is achieved. The novel union of surgeons with machines and multi-modality information, made possible by advances in engineering and computing, has enormous potential in overcoming limitations realized with contemporary standard of care. For example, a virtual model of a patient’s breast will assist the surgeon in deciding a priori what implant size to order for the operating room such that desired breast outcomes are achieved. Our long-term goal is to develop novel computer-assisted surgical systems to significantly change breast cancer health care. Our approach builds upon four broad core areas of enabling knowledge and techniques, namely (1) multi-modality imaging, (2) simulation, (3) soft tissue biomechanics, and (4) interface subsystems. Recently, we developed a parametric deformable model of a female breast’s shape that allows the surgeon to manipulate the shape of the breast by varying key shape variables, analogous to the aesthetic and structural elements surgeons inherently vary manually during breast reconstruction [2]. Such a system may enhance the practice of breast surgery at multiple points. It enables the patient to communicate her expectations more clearly to the surgeon. It allows the surgeon to educate the patient with more accurate explanations about what can be accomplished, and after the consultation, it helps the surgeon plan specific aspects of the procedure to achieve the agreed upon goals.
APA, Harvard, Vancouver, ISO, and other styles
2

Lee, Yuk Yee Karen, and Kin Yin Li. "THE LANDSCAPE OF ONE BREAST: EMPOWERING BREAST CANCER SURVIVORS THROUGH DEVELOPING A TRANSDISCIPLINARY INTERVENTION FRAMEWORK IN A JIANGMEN BREAST CANCER HOSPITAL IN CHINA." In International Psychological Applications Conference and Trends. inScience Press, 2021. http://dx.doi.org/10.36315/2021inpact003.

Full text
Abstract:
"Breast cancer is a major concern in women’s health in Mainland China. Literatures demonstrates that women with breast cancer (WBC) need to pay much effort into resisting stigma and the impact of treatment side-effects; they suffer from overwhelming consequences due to bodily disfigurement and all these experiences will be unbeneficial for their mental and sexual health. However, related studies in this area are rare in China. The objectives of this study are 1) To understand WBC’s treatment experiences, 2) To understand what kinds of support should be contained in a transdisciplinary intervention framework (TIP) for Chinese WBC through the lens that is sensitive to gender, societal, cultural and practical experience. In this study, the feminist participatory action research (FPAR) approach containing the four cyclical processes of action research was adopted. WBC’s stories were collected through oral history, group materials such as drawings, theme songs, poetry, handicraft, storytelling, and public speech content; research team members and peer counselors were involved in the development of the model. This study revealed that WBC faces difficulties returning to the job market and discrimination, oppression and gender stereotypes are commonly found in the whole treatment process. WBC suffered from structural stigma, public stigma, and self-stigma. The research findings revealed that forming a critical timeline for intervention is essential, including stage 1: Stage of suspected breast cancer (SS), stage 2: Stage of diagnosis (SD), stage 3: Stage of treatment and prognosis (ST), and stage 4: Stage of rehabilitation and integration (SRI). Risk factors for coping with breast cancer are treatment side effects, changes to body image, fear of being stigmatized both in social networks and the job market, and lack of personal care during hospitalization. Protective factors for coping with breast cancer are the support of health professionals, spouses, and peers with the same experience, enhancing coping strategies, and reduction of symptom distress; all these are crucial to enhance resistance when fighting breast cancer. Benefit finding is crucial for WBC to rebuild their self-respect and identity. Collaboration is essential between 1) Health and medical care, 2) Medical social work, 3) Peer counselor network, and 4) self-help organization to form the TIF for quality care. The research findings are crucial for China Health Bureau to develop medical social services through a lens that is sensitive to gender, societal, cultural, and practical experiences of breast cancer survivors and their families."
APA, Harvard, Vancouver, ISO, and other styles
3

Purwina, Zulfah, and Dian Sawitri. "Case Study: The Career Life Process after Treatment of Breast Cancer Survivors." In International Conference on Psychological Studies. SCITEPRESS - Science and Technology Publications, 2021. http://dx.doi.org/10.5220/0010808100003347.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vedd, Nidhi. "FATIGUE AND ANXIETY IN BREAST CANCER: THE RELATIONSHIP WITH INTERPRETATION BIAS." In International Psychological Applications Conference and Trends. inScience Press, 2021. http://dx.doi.org/10.36315/2021inpact018.

Full text
Abstract:
"Background: Research has highlighted both fatigue and anxiety to be two of the most debilitating symptoms of breast cancer that prevail for years into its survivorship, and suggests that these symptoms influence how people interpret information. Harbouring negative interpretation biases also helps to maintain self-destructive beliefs resulting in increased severity of symptoms and disability in those already affected by the illness. This study is the first utilizing an experimental measure of assessing interpretation bias in a population of breast cancer to investigate the contribution of fatigue and anxiety. Method: A cross-sectional study design was used. 53 breast cancer survivors and 62 female healthy controls were recruited via opportunistic sampling. Participants completed an online questionnaire assessing basic demographics, fatigue via the Chalder Fatigue Questionnaire (CFQ) and anxiety using the Hospital Anxiety and Depression Scale (HADS). Following this, an in-person testing session assessed interpretation bias (IB) using a computerised task. Results: Independent sample t-tests found a non-significant result in the comparison of IB indices between populations (t(112.60) =.28, p=.783; d=.05). Significant differences were observed in mean fatigue and anxiety scores in the breast cancer population compared to the healthy controls. Pearson correlation identified a statistically significant positive correlation between CFQ scores and negative interpretation bias (r=.34, n=53, p=.013), however not for anxiety. Hierarchical multiple regression was calculated to predict negative interpretation biases based on potential confounding variables (age, relationship status and level of education), CFQ, HADS anxiety scores (separately). All four regression models were non-significant. The only significant predictor of negative interpretation bias was fatigue (ß =.39, t(53)=2.71, p=.009). Conclusion: The identified significant correlation between fatigue and negative interpretation bias in this study corroborates findings from existing literature. However other results proved inconsistent with the vast body of research suggesting that breast cancer survivors would make more negative interpretations of ambiguous stimuli on an IB task compared to healthy controls. These results highlight the potential for future research investigating strategies of inherent self-adaptive and coping mechanisms that are or could be adopted by these participants to overcome this cognitive bias."
APA, Harvard, Vancouver, ISO, and other styles
5

Manikis, Georgios C., Konstantina Kourou, Paula Poikonen-Saksela, Haridimos Kondylakis, Evangelos Karademas, Kostas Marias, Dimitrios G. Katehakis, et al. "Computational Modeling of Psychological Resilience Trajectories During Breast Cancer Treatment." In 2019 IEEE 19th International Conference on Bioinformatics and Bioengineering (BIBE). IEEE, 2019. http://dx.doi.org/10.1109/bibe.2019.00082.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Qi, Ling, Jing Wang, and Hong-Ling Zhang. "Meta-analysis of Psychological Interventions on Breast Cancer Patients' Immune Function." In 2nd 2016 International Conference on Sustainable Development (ICSD 2016). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/icsd-16.2017.93.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rosa, Isabella Inês Rodrigues, Alexandre Santana Valadares, Douglas Marques de Paula, Tiago Paiva Prudente, Maria Elvira Freitas Martins, Guilherme Ferreira Barros, and Ana Laura de Sene Amâncio Zara. "ASPECTS OF BREAST CANCER DIAGNOSIS AND DELAYED TREATMENT IN BRAZIL." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2077.

Full text
Abstract:
Objective: Breast cancer is one of the leading causes of death in women worldwide. Several studies highlight the correlation between delayed treatment and high mortality. However, few researchers have addressed the main reasons for long delays in the healthcare system. This study aims to analyze different aspects influencing the postponement of treatment in Brazil. Methodology: An ecological approach using the secondary data from the Oncology Panel of the Brazilian Unified Health System (SUS). The data were collected on February 13, 2020, and included the diagnoses of breast cancer (ICD-10: C50 and D05) from 2015 to 2020. The aspects analyzed included the waiting time for the first treatment, procedure, staging, and region. Anatomopathological diagnoses made after a surgical procedure were not included. Results: According to the Brazilian laws, oncological patients need to start treatment within 60 days (5). However, the data reveal that only 45.22% of breast cancer patients (stages 2–4) started the treatment within 60 days. This is more alarming when looking at the procedures. Over half of the patients submitted to chemotherapy and 76.8% submitted to radiotherapy received their treatment after 60 days from the diagnosis. Interestingly, our geographic analysis did not reveal significant disparities among regions. The lower-income regions had 49.01–57.07% of patients treated after the recommended time frame. The higher-income regions had values from 43.44% to 54.44%. Conclusion: Despite the knowledge that later treatments result in worse outcomes and the legal right of earlier treatment, our results show a current controversial frame in Brazil. Most patients take longer than recommended, and the worst scenario is for radiotherapy patients. No substantial differences were found among lower- and higher-income regions, although it is likely that further analysis with different approaches could be more sensitive to deny or confirm this assumption.
APA, Harvard, Vancouver, ISO, and other styles
8

Lucas Amadeus, S., JD Landivar, AR Timoteo, and T. Petta Lajus. "236 Behavioral and psychological impact of oncogenetic counseling for hereditary breast cancer." In IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.236.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ruddy, KJ, A. Giobbie-Hurder, SH Giordano, S. Goldfarb, S. Kereakoglow, EP Winer, and AH Partridge. "P4-19-03: Physical and Psychological Sequelae of Breast Cancer in Men." In Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/0008-5472.sabcs11-p4-19-03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ando, N., Y. Iwamitsu, M. Kuranami, S. Okazaki, M. Wada, K. Yamamoto, M. Watanabe, and H. Miyaoka. "Analysis of factors associated with increased psychological distress in new outpatients at the breast clinic." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-3110.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Breast – Cancer – Psychological aspects"

1

Rankin, Nicole, Deborah McGregor, Candice Donnelly, Bethany Van Dort, Richard De Abreu Lourenco, Anne Cust, and Emily Stone. Lung cancer screening using low-dose computed tomography for high risk populations: Investigating effectiveness and screening program implementation considerations: An Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for the Cancer Institute NSW. The Sax Institute, October 2019. http://dx.doi.org/10.57022/clzt5093.

Full text
Abstract:
Background Lung cancer is the number one cause of cancer death worldwide.(1) It is the fifth most commonly diagnosed cancer in Australia (12,741 cases diagnosed in 2018) and the leading cause of cancer death.(2) The number of years of potential life lost to lung cancer in Australia is estimated to be 58,450, similar to that of colorectal and breast cancer combined.(3) While tobacco control strategies are most effective for disease prevention in the general population, early detection via low dose computed tomography (LDCT) screening in high-risk populations is a viable option for detecting asymptomatic disease in current (13%) and former (24%) Australian smokers.(4) The purpose of this Evidence Check review is to identify and analyse existing and emerging evidence for LDCT lung cancer screening in high-risk individuals to guide future program and policy planning. Evidence Check questions This review aimed to address the following questions: 1. What is the evidence for the effectiveness of lung cancer screening for higher-risk individuals? 2. What is the evidence of potential harms from lung cancer screening for higher-risk individuals? 3. What are the main components of recent major lung cancer screening programs or trials? 4. What is the cost-effectiveness of lung cancer screening programs (include studies of cost–utility)? Summary of methods The authors searched the peer-reviewed literature across three databases (MEDLINE, PsycINFO and Embase) for existing systematic reviews and original studies published between 1 January 2009 and 8 August 2019. Fifteen systematic reviews (of which 8 were contemporary) and 64 original publications met the inclusion criteria set across the four questions. Key findings Question 1: What is the evidence for the effectiveness of lung cancer screening for higher-risk individuals? There is sufficient evidence from systematic reviews and meta-analyses of combined (pooled) data from screening trials (of high-risk individuals) to indicate that LDCT examination is clinically effective in reducing lung cancer mortality. In 2011, the landmark National Lung Cancer Screening Trial (NLST, a large-scale randomised controlled trial [RCT] conducted in the US) reported a 20% (95% CI 6.8% – 26.7%; P=0.004) relative reduction in mortality among long-term heavy smokers over three rounds of annual screening. High-risk eligibility criteria was defined as people aged 55–74 years with a smoking history of ≥30 pack-years (years in which a smoker has consumed 20-plus cigarettes each day) and, for former smokers, ≥30 pack-years and have quit within the past 15 years.(5) All-cause mortality was reduced by 6.7% (95% CI, 1.2% – 13.6%; P=0.02). Initial data from the second landmark RCT, the NEderlands-Leuvens Longkanker Screenings ONderzoek (known as the NELSON trial), have found an even greater reduction of 26% (95% CI, 9% – 41%) in lung cancer mortality, with full trial results yet to be published.(6, 7) Pooled analyses, including several smaller-scale European LDCT screening trials insufficiently powered in their own right, collectively demonstrate a statistically significant reduction in lung cancer mortality (RR 0.82, 95% CI 0.73–0.91).(8) Despite the reduction in all-cause mortality found in the NLST, pooled analyses of seven trials found no statistically significant difference in all-cause mortality (RR 0.95, 95% CI 0.90–1.00).(8) However, cancer-specific mortality is currently the most relevant outcome in cancer screening trials. These seven trials demonstrated a significantly greater proportion of early stage cancers in LDCT groups compared with controls (RR 2.08, 95% CI 1.43–3.03). Thus, when considering results across mortality outcomes and early stage cancers diagnosed, LDCT screening is considered to be clinically effective. Question 2: What is the evidence of potential harms from lung cancer screening for higher-risk individuals? The harms of LDCT lung cancer screening include false positive tests and the consequences of unnecessary invasive follow-up procedures for conditions that are eventually diagnosed as benign. While LDCT screening leads to an increased frequency of invasive procedures, it does not result in greater mortality soon after an invasive procedure (in trial settings when compared with the control arm).(8) Overdiagnosis, exposure to radiation, psychological distress and an impact on quality of life are other known harms. Systematic review evidence indicates the benefits of LDCT screening are likely to outweigh the harms. The potential harms are likely to be reduced as refinements are made to LDCT screening protocols through: i) the application of risk predication models (e.g. the PLCOm2012), which enable a more accurate selection of the high-risk population through the use of specific criteria (beyond age and smoking history); ii) the use of nodule management algorithms (e.g. Lung-RADS, PanCan), which assist in the diagnostic evaluation of screen-detected nodules and cancers (e.g. more precise volumetric assessment of nodules); and, iii) more judicious selection of patients for invasive procedures. Recent evidence suggests a positive LDCT result may transiently increase psychological distress but does not have long-term adverse effects on psychological distress or health-related quality of life (HRQoL). With regards to smoking cessation, there is no evidence to suggest screening participation invokes a false sense of assurance in smokers, nor a reduction in motivation to quit. The NELSON and Danish trials found no difference in smoking cessation rates between LDCT screening and control groups. Higher net cessation rates, compared with general population, suggest those who participate in screening trials may already be motivated to quit. Question 3: What are the main components of recent major lung cancer screening programs or trials? There are no systematic reviews that capture the main components of recent major lung cancer screening trials and programs. We extracted evidence from original studies and clinical guidance documents and organised this into key groups to form a concise set of components for potential implementation of a national lung cancer screening program in Australia: 1. Identifying the high-risk population: recruitment, eligibility, selection and referral 2. Educating the public, people at high risk and healthcare providers; this includes creating awareness of lung cancer, the benefits and harms of LDCT screening, and shared decision-making 3. Components necessary for health services to deliver a screening program: a. Planning phase: e.g. human resources to coordinate the program, electronic data systems that integrate medical records information and link to an established national registry b. Implementation phase: e.g. human and technological resources required to conduct LDCT examinations, interpretation of reports and communication of results to participants c. Monitoring and evaluation phase: e.g. monitoring outcomes across patients, radiological reporting, compliance with established standards and a quality assurance program 4. Data reporting and research, e.g. audit and feedback to multidisciplinary teams, reporting outcomes to enhance international research into LDCT screening 5. Incorporation of smoking cessation interventions, e.g. specific programs designed for LDCT screening or referral to existing community or hospital-based services that deliver cessation interventions. Most original studies are single-institution evaluations that contain descriptive data about the processes required to establish and implement a high-risk population-based screening program. Across all studies there is a consistent message as to the challenges and complexities of establishing LDCT screening programs to attract people at high risk who will receive the greatest benefits from participation. With regards to smoking cessation, evidence from one systematic review indicates the optimal strategy for incorporating smoking cessation interventions into a LDCT screening program is unclear. There is widespread agreement that LDCT screening attendance presents a ‘teachable moment’ for cessation advice, especially among those people who receive a positive scan result. Smoking cessation is an area of significant research investment; for instance, eight US-based clinical trials are now underway that aim to address how best to design and deliver cessation programs within large-scale LDCT screening programs.(9) Question 4: What is the cost-effectiveness of lung cancer screening programs (include studies of cost–utility)? Assessing the value or cost-effectiveness of LDCT screening involves a complex interplay of factors including data on effectiveness and costs, and institutional context. A key input is data about the effectiveness of potential and current screening programs with respect to case detection, and the likely outcomes of treating those cases sooner (in the presence of LDCT screening) as opposed to later (in the absence of LDCT screening). Evidence about the cost-effectiveness of LDCT screening programs has been summarised in two systematic reviews. We identified a further 13 studies—five modelling studies, one discrete choice experiment and seven articles—that used a variety of methods to assess cost-effectiveness. Three modelling studies indicated LDCT screening was cost-effective in the settings of the US and Europe. Two studies—one from Australia and one from New Zealand—reported LDCT screening would not be cost-effective using NLST-like protocols. We anticipate that, following the full publication of the NELSON trial, cost-effectiveness studies will likely be updated with new data that reduce uncertainty about factors that influence modelling outcomes, including the findings of indeterminate nodules. Gaps in the evidence There is a large and accessible body of evidence as to the effectiveness (Q1) and harms (Q2) of LDCT screening for lung cancer. Nevertheless, there are significant gaps in the evidence about the program components that are required to implement an effective LDCT screening program (Q3). Questions about LDCT screening acceptability and feasibility were not explicitly included in the scope. However, as the evidence is based primarily on US programs and UK pilot studies, the relevance to the local setting requires careful consideration. The Queensland Lung Cancer Screening Study provides feasibility data about clinical aspects of LDCT screening but little about program design. The International Lung Screening Trial is still in the recruitment phase and findings are not yet available for inclusion in this Evidence Check. The Australian Population Based Screening Framework was developed to “inform decision-makers on the key issues to be considered when assessing potential screening programs in Australia”.(10) As the Framework is specific to population-based, rather than high-risk, screening programs, there is a lack of clarity about transferability of criteria. However, the Framework criteria do stipulate that a screening program must be acceptable to “important subgroups such as target participants who are from culturally and linguistically diverse backgrounds, Aboriginal and Torres Strait Islander people, people from disadvantaged groups and people with a disability”.(10) An extensive search of the literature highlighted that there is very little information about the acceptability of LDCT screening to these population groups in Australia. Yet they are part of the high-risk population.(10) There are also considerable gaps in the evidence about the cost-effectiveness of LDCT screening in different settings, including Australia. The evidence base in this area is rapidly evolving and is likely to include new data from the NELSON trial and incorporate data about the costs of targeted- and immuno-therapies as these treatments become more widely available in Australia.
APA, Harvard, Vancouver, ISO, and other styles
2

Greene, Mark I. Immunobiological Aspects of erbB Receptors in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, August 1999. http://dx.doi.org/10.21236/ada372252.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, October 2001. http://dx.doi.org/10.21236/ada403466.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, October 2003. http://dx.doi.org/10.21236/ada427835.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, October 2004. http://dx.doi.org/10.21236/ada431795.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, October 2002. http://dx.doi.org/10.21236/ada410581.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Andrykowski, Michael. Predoctoral Research Training Program in Biopsychosocial Aspects of Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, August 1995. http://dx.doi.org/10.21236/ada300117.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Yull, Fiona. Nf-Kappab as a Critical Biological Link Between Psychological Stress and Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, November 2007. http://dx.doi.org/10.21236/ada476464.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bovbjerg, Dana H. Psychological Stress, Neutropenia, and Infectious Disease in Patients Receiving Chemotherapy Treatment for Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 1997. http://dx.doi.org/10.21236/ada344916.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bovbjerg, Dana. Psychological Stress, Neutropenia and Infectious Disease in Patients Receiving Chemotherapy Treatment for Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 1999. http://dx.doi.org/10.21236/ada383253.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography